ACTIMED THERAPEUTICS

Live / Registered — Registered (as of 24 May 2022)

What this means for you

Registered since 24 May 2022. The owner can stop confusingly similar uses in the classes it covers.

Record

Serial number
88049205
Registration number
6734037
Mark type
Stylized text
Filed
23 Jul 2018
Published for opposition
08 Mar 2022
Registered
24 May 2022
Attorney of record
M. Scott Alprin

Goods and services

  • Class 005 — Pharmaceuticals: Pharmaceutical, medical and therapeutic substances and preparations; pharmaceutical, medical and therapeutic substances and preparations for the treatment and management of severe or chronic illnesses and diseases; pharmaceutical, medical and therapeutic substances and preparations for countering adverse effects of cancers, and of severe or chronic illnesses and diseases; pharmaceutical, medical and therapeutic substances and preparations for treatment and management of physical function; pharmaceutical, medical and therapeutic substances and preparations for treatment and prevention of muscle wasting; pharmaceutical, medical and therapeutic substances and preparations for treatment and management of patient tolerance of therapies, in particular anticancer therapy; pharmaceutical, medical and therapeutic substances and preparations for the treatment and management of cachexia, in particular cancer cachexia; pharmaceutical, medical and therapeutic substances and preparations for the treatment and management of the side effects of medical treatments, in particular of cancer treatments; pharmaceutical, medical and therapeutic substances and preparations for the treatment and management of severe or chronic illnesses and diseases of the lung; pharmaceutical, medical and therapeutic substances and preparations for the treatment and management of severe or chronic illnesses and diseases of the kidney; pharmaceutical, medical and therapeutic substances and preparations for the treatment and management of severe or chronic illnesses and diseases of the heart; pharmaceutical, medical and therapeutic substances and preparations for the treatment and management of severe or chronic illnesses and diseases of the liver; pharmaceutical, medical and therapeutic substances and preparations for the treatment and management of severe or chronic illnesses and diseases of the brain; pharmaceutical, medical and therapeutic substances and preparations for countering adverse effects of chronic heart failure; pharmaceutical, medical and therapeutic substances and preparations for countering adverse effects of chronic renal failure; pharmaceutical, medical and therapeutic substances and preparations for countering adverse effects of chronic liver failure; pharmaceutical, medical and therapeutic substances and preparations for countering adverse effects of chronic obstructive pulmonary disease; pharmaceutical, medical and therapeutic substances and preparations for countering adverse effects of neurological-muscular disorders
  • Class 044 — Medical, beauty and agricultural services: Information, advisory and consultancy services relating to medicine and healthcare; medical and surgical diagnosis and treatment services; medical analysis and reporting services relating to the treatment of patients; assessment and monitoring of patients; preparation of data and reports relating to medicine and healthcare; medical testing services relating to the diagnosis and treatment of illnesses, diseases and medical conditions; providing information relating to the management, preparation and dispensing of medications; medical, health, dentistry, veterinary and pharmaceutical services; medical diagnosis, treatment, testing, analysis, reporting, assessment and monitoring services relating to severe or chronic illnesses and diseases; medical diagnosis, treatment, testing, analysis, reporting, assessment and monitoring services relating to countering adverse effects of cancers, and of severe or chronic illnesses and diseases; medical diagnosis, treatment, testing, analysis, reporting, assessment and monitoring services relating to physical function and muscle wasting; medical diagnosis, treatment, testing, analysis, reporting, assessment and monitoring services relating to patient tolerance of therapies, in particular anticancer therapy; medical diagnosis, treatment, testing, analysis, reporting, assessment and monitoring services relating to the treatment and management of cachexia, in particular cancer cachexia; medical diagnosis, treatment, testing, analysis, reporting, assessment and monitoring services relating to the treatment and management of the side effects of medical treatments, in particular of cancer treatments; medical diagnosis, treatment, testing, analysis, reporting, assessment and monitoring services relating to the treatment and management of severe or chronic illnesses and diseases of the lung; medical diagnosis, treatment, testing, analysis, reporting, assessment and monitoring services relating to the treatment and management of severe or chronic illnesses and diseases of the kidney; medical diagnosis, treatment, testing, analysis, reporting, assessment and monitoring services relating to the treatment and management of severe or chronic illnesses and diseases of the heart; medical diagnosis, treatment, testing, analysis, reporting, assessment and monitoring services relating to the treatment and management of severe or chronic illnesses and diseases of the liver; medical diagnosis, treatment, testing, analysis, reporting, assessment and monitoring services relating to the treatment and management of severe or chronic illnesses and diseases of the brain; medical diagnosis, treatment, testing, analysis, reporting, assessment and monitoring services relating to countering adverse effects of chronic heart failure; medical diagnosis, treatment, testing, analysis, reporting, assessment and monitoring services relating to countering adverse effects of chronic renal failure; medical diagnosis, treatment, testing, analysis, reporting, assessment and monitoring services relating to countering adverse effects of chronic liver failure; medical diagnosis, treatment, testing, analysis, reporting, assessment and monitoring services relating to countering adverse effects of chronic obstructive pulmonary disease; medical diagnosis, treatment, testing, analysis, reporting, assessment and monitoring services relating to countering adverse effects of neurological-muscular disorders; advisory, information and consultancy services relating to all the aforesaid services

Owner

Prosecution history

  • 24 May 2022 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
  • 24 May 2022 — REGISTERED-PRINCIPAL REGISTER
  • 08 Mar 2022 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
  • 08 Mar 2022 — PUBLISHED FOR OPPOSITION
  • 16 Feb 2022 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
  • 27 Jan 2022 — APPROVED FOR PUB - PRINCIPAL REGISTER
  • 27 Jan 2022 — EXAMINER'S AMENDMENT ENTERED
  • 27 Jan 2022 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
  • 27 Jan 2022 — EXAMINERS AMENDMENT E-MAILED
  • 27 Jan 2022 — EXAMINERS AMENDMENT -WRITTEN
  • 16 Dec 2021 — TEAS/EMAIL CORRESPONDENCE ENTERED
  • 16 Dec 2021 — CORRESPONDENCE RECEIVED IN LAW OFFICE
  • 09 Dec 2021 — TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
  • 01 Oct 2021 — NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
  • 01 Oct 2021 — INQUIRY TO SUSPENSION E-MAILED

View this trademark record on Marksy